glp-1 adoption GLP-1s in 2025: Who's Using Them, Who's Covering Them, and What's Next US households with GLP-1 users

In 2022, Eli Lilly secured FDA approval of tirzepatide, its GLP-1 drug, to treat diabetes

Neurology 95, e1188e1198

Manufacturers have a legal duty to warn consumers about known and foreseeable dangers associated with their products

GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health

Over time, if we consistently reach for that evening drink, our body might start relying on it to initiate sleep

Folks often go for trusted brands, which has got a solid rep for consistently getting their goods and services to you on time